Received 13 March 2023 Decided — Withdrawn Request Reference FOI 23/03/003 Requester Type — Health Products Regulatory Authority (HPRA) Request for information in relation to a medicinal product - Rivaroxaban Clonmel 20mg hard caps PA0126/353/002